Cargando…
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
Enadenotucirev (EnAd) is a chimeric group B adenovirus isolated by bioselection from a library of adenovirus serotypes. It replicates selectively in and kills a diverse range of carcinoma cells, shows effective anticancer activity in preclinical systems, and is currently undergoing phase I/II clinic...
Autores principales: | Dyer, Arthur, Di, Ying, Calderon, Hugo, Illingworth, Sam, Kueberuwa, Gray, Tedcastle, Alison, Jakeman, Phil, Chia, Suet Lin, Brown, Alice, Silva, Michael A., Barlow, David, Beadle, John, Hermiston, Terry, Ferguson, David J.P., Champion, Brian, Fisher, Kerry D., Seymour, Leonard W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363721/ https://www.ncbi.nlm.nih.gov/pubmed/28345021 http://dx.doi.org/10.1016/j.omto.2016.11.003 |
Ejemplares similares
-
Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
por: Illingworth, Sam, et al.
Publicado: (2017) -
"Arming" the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours
por: Champion, Brian R, et al.
Publicado: (2014) -
Arming the oncolytic virus enadenotucirev (EnAd) to generate enhanced locally-acting immunotherapies for cancer
por: Champion, Brian R, et al.
Publicado: (2015) -
A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)
por: Machiels, Jean-Pascal, et al.
Publicado: (2019) -
Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα Activation
por: Taverner, William K., et al.
Publicado: (2019)